Belatacept (Nulojix)

belatacept · Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Belatacept (Nulojix), covering 2017-07-07 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Daratumumab and Belatacept for Desensitization [Phase 1, Phase 2]